Sergliflozin etabonate

Overview

Sergliflozin etabonate (GW-869682X) is a potent and orally active sodium glucose cotransporter ( SGLT2 ) inhibitor. Sergliflozin etabonate shows antidiabetic and antihyperglycemic effects. Sergliflozin etabonate significantly reduces non-fasting blood glucose levels in diabetic mice. Sergliflozin etabonate has the potential for the research of diabetes.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT

Product Information

• Catalog No.: HY-12611
• CAS No.: 408504-26-7
• Molecular Formula: C23H28O9
• Molecular Weight: 448.46
• Purity: 99.64%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 5 mg/mL (11.15 mM); Clear solution
• Availability: In-stock

Source

Original product source